Cancer markers refer to substances directly produced by tumor cells or induced by non-tumor cells through tumor cells.
This report contains market size and forecasts of Biomarker Testing for Cancer in global, including the following market information:
Global Biomarker Testing for Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Biomarker Testing for Cancer Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Biomarker Testing for Cancer companies in 2021 (%)
The global Biomarker Testing for Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Protein Biomarkers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biomarker Testing for Cancer include F. Hoffmann-L A Roche, Thermo Fisher Scientific, Qiagen N.V., Bio-Rad L aboratories and llumina, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biomarker Testing for Cancer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biomarker Testing for Cancer Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, by Type, 2021 (%)
Protein Biomarkers
Genetic Biomarkers
Others
Global Biomarker Testing for Cancer Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, by Application, 2021 (%)
Diagnostics
Research & Development
Prognostics
Risk Assessment
Others
Global Biomarker Testing for Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biomarker Testing for Cancer revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biomarker Testing for Cancer revenues share in global market, 2021 (%)
Key companies Biomarker Testing for Cancer sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Biomarker Testing for Cancer sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-L A Roche
Thermo Fisher Scientific
Qiagen N.V.
Bio-Rad L aboratories
llumina